Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2020 | Next-gen immuno-oncology therapies in RCC

Ziad Bakouny, MD, Dana-Farber Cancer Institute, Boston, MA, gives his thoughts on next-generation immuno-oncology therapies in renal cell carcinoma (RCC). Specifically, he highlights vaccines, new checkpoint inhibitors, and harnessing the metabolomic environment. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.